ADMA BIOLOGICS, INC. Revenue from Related Parties
ADMA BIOLOGICS, INC. (ADMA) reported Revenue from Related Parties of $0 for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-08.
Discontinued › Income Statement › Other Income
us-gaap:RevenueFromRelatedParties · last filed 2019-05-08
- ADMA BIOLOGICS, INC. revenue from related parties for the quarter ending 2019-03-31 was $0.00, a 100.00% decline year-over-year.
- ADMA BIOLOGICS, INC. revenue from related parties for the quarter ending 2018-03-31 was $2.33M.
| Period end | Revenue from Related Parties 3 month |
|---|---|
| 2019-03-31 | $0.00 10-Q · filed 2019-05-08 |
| 2018-03-31 | $2.33M 10-Q · filed 2019-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |